Richard Hoyt

Richard Hoyt

Net worth: 15 759 $ as of 31/05/2026

72 year
Health Technology
Commercial Services

Profile

Mr. Richard Hoyt is a Chairman at ZYUS Life Sciences Corp., a Vice President-Business Development at Xeris Biopharma Holdings, Inc., a Chairman at ZYUS Life Sciences, Inc. and a Managing Partner at Ozark Transaction Advisors LLC.
Mr. Hoyt was previously employed as an Independent Director by CanniMed Therapeutics, Inc., a Vice President-Business Development & Licensing by Mallinckrodt Plc, and a Vice President-Business Development by Xeris Pharmaceuticals, Inc. He also served on the board at Biotechnology Research & Development Corp.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
26/11/2025 309,002 ( 0.39% ) 15 759 $ 31/05/2026

Richard Hoyt active positions

CompaniesPositionStart
ZYUS LIFE SCIENCES CORPORATION Chairman 01/09/2020
XERIS BIOPHARMA HOLDINGS, INC. Corporate Officer/Principal 01/11/2019
Chairman -
Ozark Transaction Advisors LLC
Corporate Officer/Principal -

Former positions of Richard Hoyt

CompaniesPositionEnd
MALLINCKRODT PLC Corporate Officer/Principal 01/09/2018
CANNIMED THERAPEUTICS INC Director/Board Member 15/03/2018
Corporate Officer/Principal -
Director/Board Member -
See the detail of Richard Hoyt's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

12

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Ozark Transaction Advisors LLC

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!